Genprex
GNPX
15 hedge funds and large institutions have $153K invested in Genprex in 2025 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 3 closing their positions.
63% more capital invested
Capital invested by funds: $93.5K → $153K (+$59.4K)
33% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 3
7% more funds holding
Funds holding: 14 → 15 (+1)
3.36% more ownership
Funds ownership: 4.52% → 7.88% (+3.4%)
0% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$84.6K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$24.4K |
| 3 |
VF
Virtu Financial
New York
|
+$4.88K |
| 4 |
FIM
Freedom Investment Management
Hartford,
Connecticut
|
+$4.58K |
| 5 |
Citigroup
New York
|
+$3.36K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HighTower Advisors
Chicago,
Illinois
|
-$18K |
| 2 |
HF
HRT Financial
New York
|
-$11K |
| 3 |
TSS
Two Sigma Securities
New York
|
-$5.5K |
| 4 |
CCM
Corsair Capital Management
New York
|
-$2.45K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
-$2.44K |
GNPX Hedge Fund Activity: Q2 2025 in Review
15 of the 7,616 institutional investors tracked by Wall St. Rank reported a position in Genprex (GNPX) for Q2 2025, worth a combined $153K — up 63% from $93.5K a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new GNPX positions and 3 closed out — a net gain of 1 holder — while 3 added to existing stakes and 3 trimmed.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $84.6K. The largest seller was HighTower Advisors, cutting an estimated $18K.
- 15 institutional investors held Genprex (GNPX) as of Q2 2025, up from 14 in Q1 2025.
- Funds reported $153K of Genprex stock for Q2 2025, up 63% quarter-over-quarter.
- 4 funds opened new Genprex positions in Q2 2025 and 3 closed out, a net change of +1 holder.
- The largest Genprex buyer in Q2 2025 was Susquehanna International Group, an estimated $84.6K added.
- The largest Genprex seller in Q2 2025 was HighTower Advisors, an estimated $18K sold.
Based on aggregated 13F filings for Q2 2025.